NCT01887353 The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure Status TERMINATED Phase PHASE2
NCT01881529 A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma Status COMPLETED Phase N/A
NCT01872988 Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma Status TERMINATED Phase PHASE3
NCT01865799 A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA Status COMPLETED Phase N/A
NCT01865786 A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication Status COMPLETED Phase N/A
NCT01858766 Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection Status COMPLETED Phase PHASE2
NCT01854775 Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children Status COMPLETED Phase PHASE2/PHASE3
NCT01851330 Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3) Status COMPLETED Phase PHASE3
NCT01850212 A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects Status COMPLETED Phase N/A
NCT01847391 A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01843127 A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes. Status COMPLETED Phase PHASE1
NCT01841489 A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics Status COMPLETED Phase PHASE1
NCT01840735 Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF Status COMPLETED Phase PHASE1
NCT01838590 Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection Status COMPLETED Phase PHASE3
NCT01838434 Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma Status COMPLETED Phase PHASE1